FDA.reportPublic FDA data

Sennosides USP 25 mg Tablets

Manufacturer
TARGET CORPORATION | TIME CAP LABORATORIES, INC.
Effective date
2024-08-22
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 00:17:38

Label at a glance#

ProductMAXIMUM STRENGTH LAXATIVE PILLS
Active ingredientsennosides
Label structure9 sections

Indications and uses

relieves occasional constipation (irregularity) generally produces bowel movement in 6 to 12 hours

Dosage and administration

swallow tablet (s) with a glass of water. swallow tablet (s) whole, do not crush, break or chew. adults and children 12 years of age and older: 2 tablets once or twice daily children 6 to under 12 years of age: 1 tablet once or twice daily children under 6 years of age: ask a doctor

Storage and handling

each tablet contains: calcium 40 mg, sodium 2 mg (VERY LOW SODIUM) store between 20°-25°C (68°-77°F)

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Sennosides USP, 25 mg

Purpose

OTC - PURPOSE SECTION

Stimulant laxative

Uses

INDICATIONS & USAGE SECTION

  • relieves occasional constipation (irregularity)
  • generally produces bowel movement in 6 to 12 hours

WARNINGS SECTION

Warnings

Do not use

OTC - DO NOT USE SECTION

laxative products when abdominal pain, nausea, or vomiting are present unless directed by a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

noticed a sudden change in bowel habits that persists over a period of 2 weeks.

Ask a doctor or pharmacist before use if you

OTC - ASK DOCTOR/PHARMACIST SECTION

are taking any other drug. Laxatives may affect how other drugs work. Take this product 2 or more hours before or after other drugs.

When using this product

OTC - WHEN USING SECTION

do not use for a period longer than 1 week

Stop use and ask a doctor if

OTC - STOP USE SECTION

rectal bleeding or failure to have a bowel movement occur after use of a laxative. These may be signs of a serious condition.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

DOSAGE & ADMINISTRATION SECTION

  • swallow tablet (s) with a glass of water.
  • swallow tablet (s) whole, do not crush, break or chew.

adults and children 12 years of age and older: 2 tablets once or twice daily

children 6 to under 12 years of age: 1 tablet once or twice daily

children under 6 years of age: ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • each tablet contains: calcium 40 mg, sodium 2 mg (VERY LOW SODIUM)
  • store between 20°-25°C (68°-77°F)

Questions or comments?

OTC - QUESTIONS SECTION

Call 1-800-910-6874

Inactive ingredients

INACTIVE INGREDIENT SECTION

acacia, calcium sulfate anhydrous, carnauba wax, colloidal silicon dioxide, corn starch, croscarmellose sodium, dibasic calcium phosphate dihydrate, FD&C blue #1 aluminum lake, iron oxide, iron oxide black, iron oxide yellow, kaolin, magnesium stearate, maltodextrin, microcrystalline cellulose, polyethylene glycol, povidone, shellac, stearic acid, sugar, talc, titanium dioxide.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

sennoside-ifc-48ssennoside-ifc-48s

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
251292sennosides 25 MG Oral TabletPSN4
251292sennosides, USP 25 MG Oral TabletSCD4

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
bee4fa8d-8d82-423a-a0b5-40a89dd13a99Product name120250618
e0d2eb29-08bd-4bba-90d1-c91c68a38767Product name420250516
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2Product name520250304
334fe8d2-68fb-4331-a576-420e302ec069Product name720240320
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
e92765c1-be81-432a-b909-1b10777ec378Product name120190208
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
0441a8f5-3835-497c-aedd-bc78cba56b2aProduct name120150317
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11673-995-48MAXIMUM STRENGTH LAXATIVE PILLS48 in 1 BLISTER PACKTABLET484

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11673-995MAXIMUM STRENGTH LAXATIVE PILLS (SENNOSIDES) TABLET [TARGET CORPORATION]4Current NDC, Legacy NDC, 1 package rows20240823_7cae52ae-931c-3e7c-e053-2991aa0a8396.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 24 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11673-99511673-995-48

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 21 matching rows.

Name, UNII, Kind table
NameUNIIKind
DIBASIC CALCIUM PHOSPHATE DIHYDRATEO7TSZ97GEPIACT
KAOLIN24H4NWX5COIACT
MAGNESIUM STEARATE70097M6I30IACT
MALTODEXTRIN7CVR7L4A2DIACT
POLYETHYLENE GLYCOL 400B697894SGQIACT
RAW SUGAR8M707QY5GHIACT
CROSCARMELLOSE SODIUMM28OL1HH48IACT
FD&C BLUE NO. 1H3R47K3TBDIACT
STEARIC ACID4ELV7Z65APIACT
MICROCRYSTALLINE CELLULOSEOP1R32D61UIACT
STARCH, CORNO8232NY3SJIACT
POVIDONEFZ989GH94EIACT
SHELLAC46N107B71OIACT
FERRIC OXIDE YELLOWEX438O2MRTIACT
FERROSOFERRIC OXIDEXM0M87F357IACT
CALCIUM SULFATE ANHYDROUSE934B3V59HIACT
sennosides3FYP5M0IJXACTIB
TITANIUM DIOXIDE15FIX9V2JPIACT
CARNAUBA WAXR12CBM0EIZIACT
TALC7SEV7J4R1UIACT
ACACIA5C5403N26OIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MAXIMUM STRENGTH LAXATIVE PILLSSENNOSIDESTARGET CORPORATION7cae52ae-931c-3e7c-e053-2991aa0a83962024-08-22WarningsExact identifier
ndc (package): 11673-995-48
ndc (product): 11673-995
ndc11 (package): 11673099548
spl id: 1d7f2b9d-7103-8ee6-e063-6294a90a13cd
spl set id: 7cae52ae-931c-3e7c-e053-2991aa0a8396

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.